发明名称 |
CHEMICAL COMPOUNDS |
摘要 |
Compound of formula (I) wherein: A is a bicyclic heteroaryl, optionally substituted with one or more substituents; B is aryl or a mono or bicyclic heteroaryl, each of which can be optionally subsituted with one or more subsituents; Z is -X(CR<a>R<b>)aCO, -NH, -CO or the group X-(CH2)bCONH (CH2)cNH where X is oxygen, sulphur, amino, alkylamino or a direct bond, R<a> and R<b> are independently hydrogen or C1-4 alkyl, a is an integer from 1 to 4, b is 1 or 2 and c is from 2 to 5, and; W is -NHCH(R<w>)CO- or OC(R<w>)CHNH where R<w> is -CH2CH(CH3)2-CH2CH2S(CH3) or CH2CH2S(O2)(CH3); q is 0 or 1 and when q is 0 Z is linked to the group W by the formation of an amide bond between Z and Y, and when q is 1 Z is linked to the group W by the formation of an amide bond between Z and W and W is linked to the group Y by the formation of an amide bond between W and Y; Y is a fragment derived from the C-terminus of a compound which inhibits the interaction between the integrin alpha IIb beta 3 and its ligand fibrinogen; R<1> is hydrogen, C1-5alkyl, C1-3 alkanoyl or C1-3 alkoxycarbonyl; or a pharmaceutically acceptable salt or in vivo hydrolysable derivative thereof.
|
申请公布号 |
WO0005223(A2) |
申请公布日期 |
2000.02.03 |
申请号 |
WO1999GB02330 |
申请日期 |
1999.07.20 |
申请人 |
ZENECA LIMITED;BRITTAIN, DAVID, ROBERT;JOHNSTONE, CRAIG;DAVIES, GARETH, MORSE;LARGE, MICHAEL, STEWART |
发明人 |
BRITTAIN, DAVID, ROBERT;JOHNSTONE, CRAIG;DAVIES, GARETH, MORSE;LARGE, MICHAEL, STEWART |
分类号 |
A61K31/423;A61K31/428;A61K31/4439;A61P1/04;A61P3/10;A61P9/10;A61P11/06;A61P13/12;A61P17/06;A61P19/02;A61P25/00;A61P37/06;C04B41/45;C04B41/81;C07D263/58;C07D277/82;C07D405/12;C07D413/12;C07D413/14;C07D417/12;C07D417/14;(IPC1-7):C07D263/00 |
主分类号 |
A61K31/423 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|